Elevated expression of CD23 on peripheral blood B lymphocytes from patients with bullous pemphigoid: correlation with increased serum IgE

被引:16
作者
Inaoki, M
Sato, S
Takehara, K
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Dermatol, Kanazawa, Ishikawa 9208641, Japan
[2] Kawasaki Med Sch, Dept Dermatol, Kurashiki, Okayama 7010192, Japan
关键词
D O I
10.1016/j.jdermsci.2004.03.009
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Increased serum IgE levels are occasionally found in patients with severe bullous pemphigoid (BP). CD23, a low affinity Fc receptor for IgE, is mainly expressed on mature B lymphocytes. Studies have suggested that serum levels of soluble CD23 (sCD23) correlate with serum IgE levels and disease severity in BP. Objective: The purpose of our study is to examine whether the expression of CD23 is elevated in BP and whether this expression correlates with serum IgE levels and disease severity. Methods: We measured CD23 expression on B cells from patients with active BP, pemphigus vulgaris, pemphigus foliaceus, and atopic dermatitis (AD), as well. as healthy control subjects, using a flow cytometer. Serum levels of IgE and sCD23 were also measured. Results: The expression of CD23 was significantly higher in BP patients compared with healthy control subjects (P < 0.05), whereas the levels were normal in the other bullous diseases. CD23 expression tended to be higher in severe BP compared with moderate BP, and the levels in severe BP were comparable to the levels in AD. Furthermore, CD23 expression correlated positively with serum IgE levels (P < 0.002), and the IgE levels were significantly higher in severe BP than in moderate BID (P < 0.01). CD23 expression in BP did not correlate with sCD23 levels. Conclusions: These results suggest that the up-regulated surface CD23 on B cells may be involved in IgE synthesis and inflammatory events in BP. (C) 2004 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All. rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 33 条
[1]   IGE LEVELS IN SERA OF PATIENTS WITH PEMPHIGUS OR BULLOUS PEMPHIGOID [J].
ARBESMAN, CE ;
WYPYCH, JI ;
REISMAN, RE ;
BEUTNER, EH .
ARCHIVES OF DERMATOLOGY, 1974, 110 (03) :378-381
[2]  
ASBRINK E, 1984, ACTA DERM-VENEREOL, V64, P243
[3]   IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcεRII) [J].
Christie, G ;
Barton, A ;
Bolognese, B ;
Buckle, DR ;
Cook, RM ;
Hansbury, MJ ;
Harper, GP ;
Marshall, LA ;
McCord, ME ;
Moulder, K ;
Murdock, PR ;
Seal, SM ;
Spackman, VM ;
Weston, BJ ;
Mayer, RJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3228-3235
[4]   FC-EPSILON-RII/CD23 - THE LOW AFFINITY RECEPTOR FOR IGE [J].
CONRAD, DH .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :623-645
[5]   HUMAN RECOMBINANT INTERLEUKIN-4 INDUCES FC-EPSILON RECEPTORS (CD23) ON NORMAL HUMAN LYMPHOCYTES-B [J].
DEFRANCE, T ;
AUBRY, JP ;
ROUSSET, F ;
VANBERVLIET, B ;
BONNEFOY, JY ;
ARAI, N ;
TAKEBE, Y ;
YOKOTA, T ;
LEE, F ;
ARAI, K ;
DEVRIES, J ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1459-1467
[6]  
Delaporte E, 1996, J IMMUNOL, V157, P3642
[7]   IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in bullous pemphigoid:: Serum levels of these immunoglobulins reflect disease activity [J].
Döpp, R ;
Schmidt, E ;
Chimanovitch, I ;
Leverkus, M ;
Bröcker, EB ;
Zillikens, D .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (04) :577-583
[8]  
Furukawa Fukumi, 1994, Journal of Dermatological Science, V7, P150, DOI 10.1016/0923-1811(94)90089-2
[9]  
GAMMON WR, 1992, J AM ACAD DERMATOL, V27, P79
[10]   INTERLEUKIN-4 AND SOLUBLE CD23 AS PROGRESSION FACTORS FOR HUMAN LYMPHOCYTES-B - ANALYSIS OF THEIR INTERACTIONS WITH AGONISTS OF THE PHOSPHOINOSITIDE DUAL PATHWAY OF SIGNALING [J].
GORDON, J ;
CAIRNS, JA ;
MILLSUM, MJ ;
GILLIS, S ;
GUY, GR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (10) :1561-1565